Artwork

Sisällön tarjoaa Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)

1:00:05
 
Jaa
 

Manage episode 404900212 series 3011973
Sisällön tarjoaa Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:

  • The science behind what is happening in the body that causes weight loss while on Ozempic
  • What it was like in the 1990s and 2000s believing in a drug for a problem that the rest of the industry (including her own company) had written off
  • How weight loss was actually a goal from the very start — not just a side effect of diabetes medication like you often read today!

Sponsors:


  continue reading

103 jaksoa

Artwork
iconJaa
 
Manage episode 404900212 series 3011973
Sisällön tarjoaa Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:

  • The science behind what is happening in the body that causes weight loss while on Ozempic
  • What it was like in the 1990s and 2000s believing in a drug for a problem that the rest of the industry (including her own company) had written off
  • How weight loss was actually a goal from the very start — not just a side effect of diabetes medication like you often read today!

Sponsors:


  continue reading

103 jaksoa

Alle episoder

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas